Yifang Biotechnology (688382.SH): Net loss of 246 million yuan in 2024, narrowing losses year-on-year.

date
15:34 25/02/2025
avatar
GMT Eight
Yifang Bio-Pharmaceutical Group (688382.SH) released its 2024 annual performance bulletin announcement, reporting that the company achieved operating revenue...
Yifang Biotechnology (688382.SH) released its 2024 annual performance report, reporting that the company achieved operating income of 169 million yuan during the reporting period, a decrease of 8.85% year-on-year; net loss attributable to shareholders of the listed company was 246 million yuan, a narrowing of losses year-on-year; net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 255 million yuan, a narrowing of losses year-on-year; basic loss per share was 0.43 yuan/share.